Lennox International
LII NYSE Building Products Financials FY2016βFY2025
Lennox International's revenue fell 2.7% to $5.2 billion in fiscal 2025. Its operating margin was 20.1%, up from 19.5% a year earlier. Free cash flow was $639 million, down 18.3%. It paid out $655 million in dividends and buybacks, 103% of free cash flow. The diluted share count fell 1.1%.
What Lennox International does
No business description yet.
- Legal name
- LENNOX INTERNATIONAL INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001069202-26-000028
0001069202
Revenue and margins
Lennox International had $5.2B of revenue in fiscal 2025, down 2.7% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 15.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $639M in fiscal 2025, 12.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Lennox International returned $655M to shareholders in fiscal 2025, 103% of free cash flow. The diluted share count fell 1.1%.
Value Lennox International yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.4B and divides by 35.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 16.7x Β· peers 20.4x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Lennox International can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $36.5M | $61.1M | $69.1M | $422M | $34.7M |
| Debt incl. finance leases | $1.2B | $1.5B | $1.3B | $1.1B | $1.4B |
| Net debt / EBITDA | 1.8x | 2.0x | 1.4x | 0.6x | 1.2x |
| Debt / equity | β | β | 3.3x | 1.2x | 1.2x |
| Interest coverage | 23.6x | 17.0x | 15.3x | 26.9x | 25.5x |
| Current ratio | 1.4x | 0.9x | 1.6x | 1.6x | 1.6x |
| Quick ratio | 0.8x | 0.5x | 0.7x | 0.9x | 0.6x |
| Total assets | $2.2B | $2.6B | $2.9B | $3.6B | $4.1B |
| Total liabilities | $2.4B | $2.8B | $2.5B | $2.7B | $2.9B |
| Shareholders' equity | β$269M | β$203M | $393M | $962M | $1.2B |
| Net debt (β = net cash) | $1.2B | $1.5B | $1.2B | $725M | $1.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$1.4M
3 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 6, 2026 | Chris KoselVP-Corp Controller and CAO | Sold | 971 | $544.80 | $0.5M | Form 4 |
| Feb 25, 2026 | Shane D WallDirector | Sold | 100 | $540.01 | $0.1M | Form 4 |
| Feb 4, 2026 | Chris KoselVP-Corp Controller and CAO | Sold | 254 | $536.50 | $0.1M | Form 4 |
| Feb 4, 2026 | Todd J TeskeDirector | Sold | 700 | $533.45 | $0.4M | Form 4 |
| Nov 11, 2025 | Todd J TeskeDirector | Sold | 600 | $491.85 | $0.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 6 / 9 | 5 / 9 |
| Accruals ratio | β5.3% | β4.1% | 1.3% |
| Altman Z'' | 7.23 | 7.45 | 7.18 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Lennox International LII | $13.2B | β2.7% | 20.1% | 12.3% | 40.1% | 16.7x | 5 | |
| Fortune Brands Innovations FBIN | $5.1B | β3.2% | 11.6% | 8.2% | 7.7% | 34.7x | 6 | Compare β |
| UFP Industries UFPI | $4.4B | β5.0% | 5.8% | 4.4% | 11.8% | 18.6x | 5 | Compare β |
| Allegion ALLE | $15.2B | 7.8% | 21.1% | 16.9% | 21.5% | 22.3x | 8 | Compare β |
| A. O. Smith AOS | $8.5B | 0.3% | 19.0% | 14.3% | 30.7% | 17.1x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.6B | $3.8B | $3.9B | $3.8B | $3.6B | $4.2B | $4.7B | $5.0B | $5.3B | $5.2B |
| Gross profit | $1.1B | $1.1B | $1.1B | $1.1B | $1.0B | $1.2B | $1.3B | $1.5B | $1.8B | $1.7B |
| Research and development | $64.6M | $73.6M | $72.2M | $69.9M | $66.8M | $76.1M | $80.3M | $94.0M | $93.6M | $103M |
| Operating income | $429M | $495M | $510M | $657M | $479M | $590M | $656M | $792M | $1.0B | $1.0B |
| Interest expense | $27.0M | $30.6M | $38.3M | $47.5M | $28.3M | $25.0M | $38.7M | $51.7M | $38.7M | $40.9M |
| Pretax income | $403M | $464M | $468M | $508M | $445M | $560M | $616M | $739M | $999M | $997M |
| Income tax | $124M | $157M | $108M | $99.1M | $88.1M | $96.1M | $119M | $148M | $188M | $191M |
| Net income | $278M | $306M | $359M | $409M | $356M | $464M | $497M | $591M | $811M | $806M |
| Diluted EPS | $6.32 | $7.14 | $8.74 | $10.38 | $9.24 | $12.39 | $13.88 | $16.58 | $22.66 | $22.79 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | $374M | $325M | $496M | $396M | $612M | $516M | $302M | $736M | $946M | $758M |
| Capital expenditure | $84.3M | $98.3M | $95.2M | $106M | $78.5M | $107M | $101M | $250M | $164M | $119M |
| Free cash flow | $290M | $227M | $400M | $291M | $534M | $409M | $201M | $486M | $782M | $639M |
| Depreciation and amortization | $58.1M | $64.6M | $66.0M | $71.1M | $72.6M | $72.4M | $77.9M | $86.0M | $95.1M | $113M |
| Stock-based compensation | $31.7M | $24.9M | $26.3M | $21.3M | $24.3M | $24.3M | $21.8M | $30.1M | $28.5M | $29.1M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $94.9M | $1.8M | $545M |
| Share buybacks | $300M | $250M | $450M | $400M | $100M | $600M | $300M | $0.0M | $53.6M | $482M |
| Dividends paid | $69.0M | $79.7M | $93.9M | $111M | $118M | $127M | $142M | $153M | $160M | $173M |
| Dividends and buybacks | $369M | $330M | $544M | $511M | $218M | $727M | $442M | $153M | $214M | $655M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $50.2M | $68.2M | $46.3M | $40.2M | $129M | $36.5M | $61.1M | $69.1M | $422M | $34.7M |
| Total debt | $868M | $1.0B | $1.0B | $1.2B | $981M | $1.2B | $1.5B | $1.3B | $1.1B | $1.4B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $33.7M | $39.4M | $40.3M | $39.5M | $44.8M | $54.4M | $68.9M |
| Current assets | $1.0B | $1.1B | $1.1B | $1.1B | $1.1B | $1.2B | $1.5B | $1.6B | $2.0B | $1.9B |
| Current liabilities | $889M | $655M | $1.0B | $1.0B | $701M | $827M | $1.6B | $1.0B | $1.3B | $1.2B |
| Inventory | $419M | $484M | $510M | $544M | $439M | $511M | $753M | $842M | $853M | $1.2B |
| Property and equipment, net | $361M | $398M | $408M | $445M | $464M | $515M | $549M | $720M | $800M | $887M |
| Total assets | $1.8B | $1.9B | $1.8B | $2.0B | $2.0B | $2.2B | $2.6B | $2.9B | $3.6B | $4.1B |
| Total liabilities | $1.7B | $1.8B | $2.0B | $2.2B | $2.0B | $2.4B | $2.8B | $2.5B | $2.7B | $2.9B |
| Shareholders' equity | $38.0M | $50.1M | β$150M | β$170M | β$17.1M | β$269M | β$203M | $393M | $962M | $1.2B |
| Margins | ||||||||||
| Gross margin | 29.6% | 29.3% | 28.6% | 28.4% | 28.6% | 28.3% | 27.2% | 31.1% | 33.3% | 33.4% |
| Operating margin | 11.8% | 12.9% | 13.1% | 17.3% | 13.2% | 14.1% | 13.9% | 15.9% | 19.5% | 20.1% |
| EBITDA margin | 13.4% | 14.6% | 14.8% | 19.1% | 15.2% | 15.8% | 15.6% | 17.6% | 21.3% | 22.2% |
| Net margin | 7.6% | 8.0% | 9.2% | 10.7% | 9.8% | 11.1% | 10.5% | 11.9% | 15.2% | 15.5% |
| FCF margin | 8.0% | 5.9% | 10.3% | 7.6% | 14.7% | 9.7% | 4.3% | 9.8% | 14.6% | 12.3% |
| Returns | ||||||||||
| Return on capital | 35.8% | 35.5% | 42.9% | 58.6% | 42.8% | 55.4% | 48.3% | 43.8% | 50.9% | 40.1% |
| Return on capital employed | 49.8% | 46.9% | 49.9% | 71.4% | 40.5% | 44.1% | 56.7% | 54.6% | 49.2% | 40.1% |
| Return on equity | β | β | β | β | β | β | β | β | 119.7% | 75.8% |
| Return on assets | 16.2% | 16.7% | 19.4% | 21.2% | 17.5% | 22.1% | 21.0% | 21.5% | 24.7% | 20.9% |
| Growth | ||||||||||
| Revenue growth | 5.0% | 5.4% | 1.2% | β2.0% | β4.6% | 15.4% | 12.5% | 5.6% | 7.2% | β2.7% |
| Net income growth | 48.9% | 10.0% | 17.4% | 13.8% | β12.8% | 30.2% | 7.1% | 18.9% | 37.2% | β0.7% |
| EPS growth | 54.5% | 13.0% | 22.4% | 18.8% | β11.0% | 34.1% | 12.0% | 19.5% | 36.7% | 0.6% |
| FCF growth | 2.1% | β21.7% | 76.5% | β27.4% | 83.8% | β23.5% | β50.8% | 141.6% | 60.9% | β18.3% |
| Share count change | β3.5% | β2.7% | β4.0% | β4.1% | β2.0% | β2.9% | β4.5% | β0.3% | 0.3% | β1.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.7x | 1.7x | 1.7x | 1.6x | 1.6x | 1.8x | 2.0x | 1.4x | 0.6x | 1.2x |
| Debt / equity | β | β | β | β | β | β | β | 3.3x | 1.2x | 1.2x |
| Interest coverage | 15.9x | 16.2x | 13.3x | 13.8x | 16.9x | 23.6x | 17.0x | 15.3x | 26.9x | 25.5x |
| Current ratio | 1.1x | 1.7x | 1.1x | 1.1x | 1.6x | 1.4x | 0.9x | 1.6x | 1.6x | 1.6x |
| Quick ratio | 0.7x | 1.0x | 0.6x | 0.6x | 0.9x | 0.8x | 0.5x | 0.7x | 0.9x | 0.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.3% | 2.6% | 2.5% | 2.8% | 2.2% | 2.6% | 2.1% | 5.0% | 3.1% | 2.3% |
| Stock comp / revenue | 0.9% | 0.7% | 0.7% | 0.6% | 0.7% | 0.6% | 0.5% | 0.6% | 0.5% | 0.6% |
| Payouts / FCF | 127.4% | 145.4% | 135.9% | 175.7% | 40.9% | 177.8% | 219.7% | 31.6% | 27.4% | 102.6% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 7.0 | 5.0 | 6.0 | 7.0 | 6.0 | 5.0 | 8.0 | 6.0 | 5.0 |
| Altman Z'' | 4.6 | 6.2 | 5.4 | 5.9 | 6.7 | 6.8 | 5.3 | 7.2 | 7.5 | 7.2 |
| Accruals ratio | β5.6% | β1.1% | β7.4% | 0.7% | β12.6% | β2.5% | 8.2% | β5.3% | β4.1% | 1.3% |
Source: SEC EDGAR XBRL filings (CIK 0001069202). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.